Innate Pharma SA announces today its financial results for the first half of 2010.
Half-year report on INNATE PHARMA’S liquidity contract with NATIXIS SECURITIES
Innate Pharma releases its total number of shares outstanding as well as its voting rights as at April 30, 2010
Please visit the dedicated section of "regulated information in France".
